Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/1994
03/31/1994WO1994006932A1 A process of quantifying cell number
03/31/1994WO1994006919A2 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
03/31/1994WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
03/31/1994WO1994006912A1 Epstein-barr virus peptides and antibodies against these peptides
03/31/1994WO1994006904A1 Novel infectious bursal disease virus
03/31/1994WO1994006827A1 Synthetic peptide vaccine for chlamydia trachomatis
03/31/1994WO1994006826A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis
03/31/1994WO1994006818A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
03/31/1994WO1994006812A1 Green fluorescent labeled nucleotides for use in probes
03/31/1994WO1994006745A1 Method for making valproic acid derivatives
03/31/1994WO1994006474A1 ANTIBODY TREATMENT OF $i(HELICOBACTER PYLORI)
03/31/1994WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines
03/31/1994WO1994006470A1 Immunoreactive peptides from epstein-barr virus
03/31/1994WO1994006463A1 Immortalized cells and uses therefor
03/31/1994WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
03/31/1994WO1994006345A2 Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof
03/31/1994WO1994006290A1 Preserved, non-infectious control cells for use in the identification of a disease through blood testing
03/31/1994WO1994003611A3 Ptp-d subfamily of protein tyrosine phosphatases
03/31/1994WO1994003602A3 A novel human dopamine receptor and its uses
03/31/1994WO1994001547A3 A method for generation of antibodies to cell surface molecules
03/31/1994WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
03/31/1994DE4333320A1 Asphalt sampler assembly minimising health risks and maximising solvent recovery and reuse - with sieve tower either in solvent sepn. and recovery unit circuit, or in drying assembly flow circuit
03/31/1994DE4331881A1 Automated analyser for blood coagulation tests - includes a carousel holding numerous modules, each contg. a test cell and fitted with system for detecting scattered light
03/31/1994DE4232528A1 Quantitative determination of degree of hardening of lacquer layers pref. on optical fibres - by solvent extracting layer then chromatographically separating unreacted monomer and determining monomer content by UV spectroscopy
03/31/1994DE4232509A1 Measuring contaminants in containers,e.g. plastic bottles - involves using mass spectrometer with ionisation and photon stimulation
03/31/1994DE4232281C1 Determining substance concn. in environment - by measuring effects on plants, to determine pollutant concn. or optimal plant culture conditions
03/31/1994CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
03/31/1994CA2145389A1 Quantitative measurement of ldl
03/31/1994CA2145092A1 Conjugate for the detection and/or assay of a biological compound
03/31/1994CA2144882A1 Synthetic peptide vaccine for chlamydia trachomatis
03/31/1994CA2144742A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
03/31/1994CA2144651A1 Immortalized cells and uses therefor
03/31/1994CA2144511A1 Methods and kits for evaluating risk of developing periodontitis
03/31/1994CA2144435A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis
03/31/1994CA2143945A1 A method for the detection and treatment of prostate disease
03/31/1994CA2143764A1 Self-confirming assay devices
03/31/1994CA2143758A1 Preserved, non-infectious control cells for use in the identification of a disease through blood testing
03/31/1994CA2122816A1 Method for making valproic acid derivatives
03/30/1994EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype
03/30/1994EP0589772A1 Plate apparatus for mechanical testing of soils and vehicle equipped with this apparatus
03/30/1994EP0589636A1 Magnetic separation method
03/30/1994EP0589612A2 Label trapping, nonseparation binding assay
03/30/1994EP0589556A2 Carbohydrate-based anti-inflammatory agents
03/30/1994EP0589546A2 Apparatus for measuring the total organic carbon and nitrogen content of water
03/30/1994EP0589503A1 Hydrogen sulfide gas sensor and precursor compounds for manufacture of same
03/30/1994EP0589487A1 Monoclonal antibodies for small organic molecules
03/30/1994EP0589384A2 Method for determining experimentally the parameters for optimal results
03/30/1994EP0589372A2 Method of detecting liquids in fibrous and/or porous materials
03/30/1994EP0589348A2 Method for immunological quantification of inactivated antigenes
03/30/1994EP0589011A1 METHOD FOR THE DETERMINATION OF PLASMIN/$g(a)2-ANTIPLASMIN COMPLEXES AND THE USE OF THIS METHOD AS A MEAN OF DETERMINING CHANGES IN THE FIBRINOLYTIC SYSTEM
03/30/1994EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
03/30/1994EP0589001A1 Determination of glycated hemoglobin by fluorescence quenching
03/30/1994EP0588972A1 Optical imaging for positioning and cell counting
03/30/1994EP0588969A1 Optical imaging for agglutination detection
03/30/1994EP0588968A1 Liquid dispensing mechanism
03/30/1994EP0588967A1 Multiple reaction well cartridge
03/30/1994EP0588958A1 Assay for the detection of specific ligands
03/30/1994EP0588931A1 Automated specimen analyzing apparatus and method
03/30/1994EP0588903A1 Soluble hla cross-match
03/30/1994EP0588891A1 Method and sensor means for determining myocardial infarction markers
03/30/1994EP0588866A1 Device for determining the foaming properties of an at least partially soluble material.
03/30/1994EP0588844A1 Improvements in or relating to centrifuges and associated apparatus and methods.
03/30/1994EP0588831A1 Analytical methods
03/30/1994EP0539456B1 Device for continuously detecting contrast impurities contained in a moving fluid material
03/30/1994EP0329794B1 Method for assaying human lung surface active substance
03/30/1994CN1084638A Test method for determining thinness of textile fibre by the method o twice axial compressed air-flow
03/29/1994US5299319 High performance interlock collapsing SCISM ALU apparatus
03/29/1994US5299141 Automatic fluid monitoring and sampling apparatus and method
03/29/1994US5299140 Means and method for measurement of porous materials
03/29/1994US5298860 Method of analyzing metal impurities in surface oxide film of semiconductor substrate
03/29/1994US5298783 Combined semiconductor gas sensor
03/29/1994US5298605 Diabetes
03/29/1994US5298599 Fusion protein
03/29/1994US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
03/29/1994US5298583 Polymer dyestuffs and preparation and use thereof
03/29/1994US5298522 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
03/29/1994US5298491 Analytical kit
03/29/1994US5298490 Tetra and penta-peptides useful in regulating the immune system
03/29/1994US5298430 Molded and compressed into predetermined shape
03/29/1994US5298429 Monitoring transcription of reporter gene
03/29/1994US5298427 Chemiluminescent detection of amino acids
03/29/1994US5298426 Method of differentiating erythroblasts from other cells by flow cytometry
03/29/1994US5298419 Diagnosis
03/29/1994US5298407 DNA encoding a protein active in lymphocyte-mediated cytotoxicity
03/29/1994US5298406 Formulation for stabilizing enzymatic activity and immunoreactivity of creatine kinase and creatine kinase isoenzymes
03/29/1994US5298403 Labeled drug hapten analogues for immunoassays
03/29/1994US5298401 Process for the quantitative determination of the function and antigenic concentration of a substance contained in a biological liquid
03/29/1994US5298400 Genetic engineering and gene expression
03/29/1994US5298397 Reacting liqid phase with solid phase containg antibody, separation of phases, measuring bind antibody to solid phase
03/29/1994US5298396 Exposure to superantigen and detecting a form of the T-cell antigen receptor
03/29/1994US5298395 Hyperglycosylated cytokine conjugates
03/29/1994US5298394 Antigen-antibody reaction
03/29/1994US5298393 Monoclonal antibody for human acid-glutathione S-transferase and process for preparation thereof
03/29/1994US5298392 Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor
03/29/1994US5298391 Use of the SP-2 monoclonal antibody for the clinical diagnostics and for the monitoring of the HIV infection progress
03/29/1994US5298224 Apparatus for determination of the coagulation time of a blood sample
03/29/1994US5298197 Oil phase consisting fluorescer compound and oxalates, aqueous phase containing oxidizer, and surfactant
03/29/1994US5298146 Device for the simultaneous detection of dissimilar gas components
03/29/1994US5298135 Production of electrophoretically-homogenous protein-colloidal gold complexes
03/29/1994US5298122 Measuring device and method for measuring the crosswise profile of a paper web